These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 10499773)

  • 1. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
    Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
    Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
    Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
    Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
    Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
    Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy.
    Ruhnau KJ; Meissner HP; Finn JR; Reljanovic M; Lobisch M; Schütte K; Nehrdich D; Tritschler HJ; Mehnert H; Ziegler D
    Diabet Med; 1999 Dec; 16(12):1040-3. PubMed ID: 10656234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy.
    Didangelos T; Karlafti E; Kotzakioulafi E; Kontoninas Z; Margaritidis C; Giannoulaki P; Kantartzis K
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasudil combined with methylcobalamin or lipoic acid can improve the nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis.
    Jiang DQ; Xu LC; Jiang LL; Li MX; Wang Y
    Medicine (Baltimore); 2018 Jul; 97(27):e11390. PubMed ID: 29979431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term metabolic change is associated with improvement in measures of diabetic neuropathy: a 1-year placebo cohort analysis.
    Perkins BA; Dholasania A; Buchanan RA; Bril V
    Diabet Med; 2010 Nov; 27(11):1271-9. PubMed ID: 20950385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
    Ziegler D
    Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocotrienol-Rich Vitamin E (Tocovid) Improved Nerve Conduction Velocity in Type 2 Diabetes Mellitus Patients in a Phase II Double-Blind, Randomized Controlled Clinical Trial.
    Chuar PF; Ng YT; Phang SCW; Koay YY; Ho JI; Ho LS; Botross Henien NP; Ahmad B; Abdul Kadir K
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes.
    Ekberg K; Brismar T; Johansson BL; Jonsson B; Lindström P; Wahren J
    Diabetes; 2003 Feb; 52(2):536-41. PubMed ID: 12540632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double-blind randomized placebo-controlled clinical trial.
    Heydari M; Homayouni K; Hashempur MH; Shams M
    J Diabetes; 2016 Mar; 8(2):246-52. PubMed ID: 25800045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
    Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
    Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranirestat for the management of diabetic sensorimotor polyneuropathy.
    Bril V; Hirose T; Tomioka S; Buchanan R;
    Diabetes Care; 2009 Jul; 32(7):1256-60. PubMed ID: 19366965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy].
    Gu XM; Zhang SS; Wu JC; Tang ZY; Lu ZQ; Li H; Liu C; Chen L; Ning G
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2473-6. PubMed ID: 21092474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group.
    Santiago JV; Snksen PH; Boulton AJ; Macleod A; Beg M; Bochenek W; Graepel GJ; Gonen B
    J Diabetes Complications; 1993; 7(3):170-8. PubMed ID: 8343611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Tocotrienol-Rich Vitamin E (Tocovid) on Diabetic Neuropathy: A Phase II Randomized Controlled Trial.
    Ng YT; Phang SCW; Tan GCJ; Ng EY; Botross Henien NP; M Palanisamy UD; Ahmad B; Abdul Kadir K
    Nutrients; 2020 May; 12(5):. PubMed ID: 32456230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial.
    Jamal GA; Carmichael H
    Diabet Med; 1990 May; 7(4):319-23. PubMed ID: 2159860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy.
    Han T; Bai J; Liu W; Hu Y
    Eur J Endocrinol; 2012 Oct; 167(4):465-71. PubMed ID: 22837391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients.
    Ziegler D; Wiefels K; Dannehl K; Gries FA
    Klin Wochenschr; 1988 May; 66(9):388-96. PubMed ID: 2839729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.